Try our mobile app
Exhibit 99
Silicon Labs Announces Record IoT Revenue for Fourth Quarter 2021
IoT Leader Enters 2022 With Strong Momentum Across Wireless Portfolio
AUSTIN, Texas – February 2, 2022 – Silicon Labs (NASDAQ: SLAB), a leader in secure, intelligent wireless technology for a more connected world, reported strong financial results for the fourth quarter, which ended January 1, 2022. Revenue exceeded the top of the guidance range at $209 million, up 13% sequentially and 43% year-on-year. Fourth quarter and annual results herein are from “continuing operations” unless explicitly stated.
“I’m proud of the team’s disciplined execution as we transitioned to focus solely on the Internet of Things. We delivered record IoT revenue and gained momentum across our entire wireless portfolio,” said Matt Johnson, President, and Chief Executive Officer. “We’re well-positioned to take advantage of the accelerating IoT growth across smart home, medical, industrial, and commercial segments in 2022.”
Fourth Quarter Financial Highlights
| · | Revenue increased to $209 million, up 13% sequentially and 43% year-on-year |
Results on a GAAP basis:
| · | GAAP gross margin was 61.3% |
| · | GAAP R&D expenses were $72 million |
| · | GAAP SG&A expenses were $53 million |
| · | GAAP operating income as a percentage of revenue was 1.3% |
| · | GAAP diluted earnings per share were $0.13 |
Results on a non-GAAP basis, excluding the impact of stock compensation, amortization of acquired intangible assets, restructuring charges, non-cash interest expense and other costs associated with convertible notes, and certain other items as set forth in the reconciliation tables were as follows:
| · | Non-GAAP gross margin was 61.4% |
| · | Non-GAAP R&D expenses were $57 million |
| · | Non-GAAP SG&A expenses were $37 million |
| · | Non-GAAP operating income as a percentage of revenue was 16.3% |
| · | Non-GAAP diluted earnings per share were $0.77 |
Business Highlights
| · | In January, Silicon Labs announced the BG24 and MG24 2.4 GHz wireless SoCs and a new software toolkit that bring AI/ML acceleration and wireless high performance to battery-powered edge devices. Matter-ready, the ultra-low-power BG24 and MG24 families support multiple wireless protocols and incorporate PSA Level 3 Secure Vault™ protection, important for diverse smart home, medical and industrial applications. |
| · | In Q4, Silicon Labs launched our new Z-Wave 800 SoCs and modules for the Z-Wave smart home and automation ecosystem. This expansion on the company’s award-winning Series 2 platform provides developers with sub-GHz connectivity for Z-Wave Mesh and Z-Wave Long Range, which is ideal for the smart home as well as multi-dwelling units, hospitality, and lighting applications while supporting both devices and gateways. |
| · | Silicon Labs is proud to be named the Global Semiconductor Alliance’s Most Respected Public Semiconductor Company among our peers, a testament to our strong performance and values. We were also ranked one of the best companies to work for in our industry based on the annual Great Place to Work survey of our employees. |
| · | On January 27, 2022, Silicon Labs’ board of directors approved a new share repurchase program that authorizes the company to buy back up to $250 million of the company’s common stock through the end of the fiscal year. |
| · | Silicon Labs announced that Sherri Luther, Chief Financial Officer of Lattice Semiconductor (NASDAQ: LSCC), joined Silicon Labs’ board of directors effective January 2, 2022. Sherri is a well-respected industry leader, bringing 30 years of experience in mergers and acquisitions, global supply chain optimization, and deep financial expertise. Additionally, Sumit Sadana was appointed Lead Director for Silicon Labs. Sumit succeeds Bill Wood, who remains a member of the board. Sumit currently serves as Executive Vice President, Chief Business Officer, and interim Chief Financial Officer at Micron Technology (NASDAQ: MU). |
Business Outlook
The company expects first quarter revenue to be in the range of $220 to $230 million. The company also estimates the following results:
On a GAAP basis:
| · | GAAP gross margin of approximately 63% |
| · | GAAP operating expenses of approximately $128 million |
| · | GAAP effective tax rate of approximately 37% |
| · | GAAP diluted earnings per share to be between $0.15 to $0.25 |
On a non-GAAP basis, excluding the impact of stock compensation, amortization of acquired intangible assets, and certain other items as set forth in the reconciliation tables:
| · | Non-GAAP gross margin of approximately 63% |
| · | Non-GAAP operating expenses of approximately $105 million |
| · | Non-GAAP effective tax rate of approximately 30% |
| · | Non-GAAP diluted earnings per share between $0.58 to $0.68 |
Earnings Webcast and Conference Call
Silicon Labs will host an earnings conference call to discuss the quarterly results and answer questions at 7:30 am CDT today. An audio webcast will be available on Silicon Labs’ website (www.silabs.com) under Investor Relations. In addition, the company will post an audio recording of the event at silabs.com/investors and make a replay available through March 2, 2022, online or by calling (877) 344-7529 (US) or (412) 317-0088 (international) and entering access code 4909009.
About Silicon Labs
Silicon Labs (NASDAQ: SLAB) is a leader in secure, intelligent wireless technology for a more connected world. Our integrated hardware and software platform, intuitive development tools, thriving ecosystem, and robust support make us an ideal long-term partner in building advanced industrial, commercial, home and life applications. We make it easy for developers to solve complex wireless challenges throughout the product lifecycle and get to market quickly with innovative solutions that transform industries, grow economies, and improve lives. silabs.com
Forward-Looking Statements
This press release contains forward-looking statements based on Silicon Labs’ current expectations. The words “believe,” “estimate,” “expect,” “intend,” “anticipate,” “plan,” “project,” “will,” and similar phrases as they relate to Silicon Labs are intended to identify such forward-looking statements. These forward-looking statements reflect the current views and assumptions of Silicon Labs and are subject to various risks and uncertainties that could cause actual results to differ materially from expectations. Among the factors that could cause actual results to differ materially from those in the forward-looking statements are the following: the effect of the Skyworks transaction on the ability of Silicon Labs to retain and hire key personnel and maintain relationships with its customers, suppliers, advertisers, partners and others with whom it does business, or on its operating results and businesses generally; risks associated with the disruption of management’s attention from ongoing business operations due to such transaction; the timing and scope of anticipated share repurchases, and/or dividends; the impact of COVID-19 on the U.S. and global economy, including the restrictions on travel and transportation and other actions taken by governmental authorities and disruptions to the business of our customers or our global supply chain that have occurred or may occur in the future, the ongoing impact of COVID-19 on our employees and our ability to provide services to our customers and respond to their needs; risks that Silicon Labs may not be able to maintain its historical growth; quarterly fluctuations in revenues and operating results; difficulties developing new products that achieve market acceptance; risks associated with international activities (including trade barriers, particularly with respect to China); intellectual property litigation risks; risks associated with acquisitions and divestitures; product liability risks; difficulties managing and/or obtaining sufficient supply from Silicon Labs’ distributors, manufacturers and subcontractors; dependence on a limited number of products; absence of long-term commitments from customers; inventory-related risks; difficulties managing international activities; risks that Silicon Labs may not be able to manage strains associated with its growth; credit risks associated with its accounts receivable; dependence on key personnel; stock price volatility; geographic concentration of manufacturers, assemblers, test service providers and customers in Asia that subjects Silicon Labs’ business and results of operations to risks of natural disasters, epidemics or pandemics, war and political unrest; debt-related risks; capital-raising risks; the competitive and cyclical nature of the semiconductor industry; average selling prices of products may decrease significantly and rapidly; information technology risks; cyber-attacks against Silicon Labs’ products and its networks and other factors that are detailed in the SEC filings of Silicon Laboratories Inc. The level of share repurchases and/or dividends depends on market conditions and the level of other uses of cash. Silicon Labs disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. References in this press release to Silicon Labs shall mean Silicon Laboratories Inc.
Note to editors: Silicon Laboratories, Silicon Labs, the “S” symbol, and the Silicon Labs logo are trademarks of Silicon Laboratories Inc. All other product names noted herein may be trademarks of their respective holders.
CONTACT: Austin Dean, Investor Relations Manager, +1 (512) 532-9432, Austin.Dean@silabs.com
Silicon Laboratories Inc.
Condensed Consolidated Statements of Operations
(In thousands, except per share data)
(Unaudited)
| Three Months Ended | Year Ended | |||||||||||||||
| January 1, 2022 | January 2, 2021 | January 1, 2022 | January 2, 2021 | |||||||||||||
| Revenues | $ | 208,680 | $ | 145,829 | $ | 720,860 | $ | 510,928 | ||||||||
| Cost of revenues | 80,849 | 61,894 | 295,468 | 216,083 | ||||||||||||
| Gross profit | 127,831 | 83,935 | 425,392 | 294,845 | ||||||||||||
| Operating expenses: | ||||||||||||||||
| Research and development | 71,705 | 60,554 | 273,208 | 235,185 | ||||||||||||
| Selling, general and administrative | 53,487 | 41,792 | 185,022 | 166,748 | ||||||||||||
| Operating expenses | 125,192 | 102,346 | 458,230 | 401,933 | ||||||||||||
| Operating income (loss) | 2,639 | (18,411 | ) | (32,838 | ) | (107,088 | ) | |||||||||
| Other income (expense): | ||||||||||||||||
| Interest income and other, net | 2,595 | 1,206 | 5,696 | 9,027 | ||||||||||||
| Interest expense | (6,628 | ) | (8,219 | ) | (31,033 | ) | (34,142 | ) | ||||||||
| Loss from continuing operations before income taxes | (1,394 | ) | (25,424 | ) | (58,175 | ) | (132,203 | ) | ||||||||
| Provision (benefit) for income taxes | 884 | (2,702 | ) | 13,427 | (14,602 | ) | ||||||||||
| Equity-method earnings | 7,791 | 1,375 | 13,728 | 2,116 | ||||||||||||
| Income (loss) from continuing operations | 5,513 | (21,347 | ) | (57,874 | ) | (115,485 | ) | |||||||||
| Income (loss) from discontinued operations, net of income taxes | (8,611 | ) | 30,295 | 2,175,273 | 128,016 | |||||||||||
| Net income (loss) | $ | (3,098 | ) | $ | 8,948 | $ | 2,117,399 | $ | 12,531 | |||||||
| Basic earnings (loss) per share: | ||||||||||||||||
| Continuing operations | $ | 0.14 | $ | (0.49 | ) | $ | (1.35 | ) | $ | (2.64 | ) | |||||
| Net income | $ | (0.08 | ) | $ | 0.20 | $ | 49.44 | $ | 0.29 | |||||||
| Diluted earnings (loss) per share: | ||||||||||||||||
| Continuing operations | $ | 0.13 | $ | (0.49 | ) | $ | (1.35 | ) | $ | (2.64 | ) | |||||
| Net income | $ | (0.08 | ) | $ | 0.20 | $ | 47.78 | $ | 0.28 | |||||||
| Weighted-average common shares outstanding: | ||||||||||||||||
| Basic | 38,965 | 43,895 | 42,830 | 43,775 | ||||||||||||
| Diluted | 41,031 | 44,729 | 44,315 | 44,372 | ||||||||||||
Silicon Laboratories Inc.
Condensed Consolidated Balance Sheets
(In thousands, except per share data)
(Unaudited)
| January 1, 2022 | January 2, 2021 | |||||||
| Assets | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ | 1,074,623 | $ | 202,720 | ||||
| Short-term investments | 964,582 | 521,963 | ||||||
| Accounts receivable, net | 98,313 | 95,169 | ||||||
| Inventories | 49,307 | 47,861 | ||||||
| Prepaid expenses and other current assets | 51,748 | 87,103 | ||||||
| Current assets of discontinued operations | -- | 21,005 | ||||||
| Total current assets | 2,238,573 | 975,821 | ||||||
| Property and equipment, net | 146,516 | 135,803 | ||||||
| Goodwill | 376,389 | 376,389 | ||||||
| Other intangible assets, net | 118,978 | 163,483 | ||||||
| Other assets, net | 77,839 | 76,675 | ||||||
| Non-current assets of discontinued operations | -- | 265,316 | ||||||
| Total assets | $ | 2,958,295 | $ | 1,993,487 | ||||
| Liabilities and Stockholders’ Equity | ||||||||
| Current liabilities: | ||||||||
| Accounts payable | $ | 47,327 | $ | 54,949 | ||||
| Current portion of convertible debt, net | 450,599 | 134,480 | ||||||
| Deferred revenue and returns liability | 13,849 | 12,986 | ||||||
| Other current liabilities | 157,052 | 81,650 | ||||||
| Current liabilities of discontinued operations | -- | 433 | ||||||
| Total current liabilities | 668,827 | 284,498 | ||||||
| Convertible debt, net | -- | 428,945 | ||||||
| Other non-current liabilities | 77,044 | 79,752 | ||||||
| Non-current liabilities of discontinued operations | -- | 451 | ||||||
| Total liabilities | 745,871 | 793,646 | ||||||
| Commitments and contingencies | ||||||||
| Stockholders’ equity: | ||||||||
| Preferred stock – $0.0001 par value; 10,000 shares authorized; no shares issued | -- | -- | ||||||
| Common stock – $0.0001 par value; 250,000 shares authorized; 38,481 and 43,925 shares issued and outstanding at January 1, 2022 and January 2, 2021, respectively | 4 | 4 | ||||||
| Additional paid-in capital | -- | 204,359 | ||||||
| Retained earnings | 2,214,839 | 993,664 | ||||||
| Accumulated other comprehensive income (loss) | (2,419 | ) | 1,814 | |||||
| Total stockholders’ equity | 2,212,424 | 1,199,841 | ||||||
| Total liabilities and stockholders’ equity | $ | 2,958,295 | $ | 1,993,487 | ||||
Silicon Laboratories Inc.
Condensed Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)
| Year Ended | ||||||||
| January 1, 2022 | January 2, 2021 | |||||||
| Operating Activities | ||||||||
| Net income | $ | 2,117,399 | $ | 12,531 | ||||
| Adjustments to reconcile net income to cash provided by (used in) operating activities of continuing operations: | ||||||||
| Income from discontinued operations, net of income taxes | (2,175,273 | ) | (128,016 | ) | ||||
| Depreciation of property and equipment | 18,051 | 16,267 | ||||||
| Amortization of other intangible assets | 44,505 | 42,569 | ||||||
| Amortization of debt discount and debt issuance costs | 22,767 | 21,433 | ||||||
| Loss on extinguishment of convertible debt | 3,370 | 4,060 | ||||||
| Stock-based compensation expense | 56,842 | 49,454 | ||||||
| Equity-method earnings | (13,728 | ) | (2,116 | ) | ||||
| Deferred income taxes | (3,414 | ) | (6,533 | ) | ||||
| Changes in operating assets and liabilities: | ||||||||
| Accounts receivable | (3,144 | ) | (17,612 | ) | ||||
| Inventories | (1,510 | ) | 9,148 | |||||
| Prepaid expenses and other assets | 44,664 | (50,664 | ) | |||||
| Accounts payable | (7,704 | ) | 15,263 | |||||
| Other current liabilities and income taxes | 2,109 | 3,215 | ||||||
| Deferred revenue and returns liability | 863 | (6,694 | ) | |||||
| Other non-current liabilities | (14,599 | ) | 28,856 | |||||
| Net cash provided by (used in) operating activities of continuing operations | 91,198 | (8,839 | ) | |||||
| Investing Activities | ||||||||
| Purchases of marketable securities | (1,541,971 | ) | (519,567 | ) | ||||
| Sales and maturities of marketable securities | 1,095,041 | 497,357 | ||||||
| Purchases of property and equipment | (28,577 | ) | (18,088 | ) | ||||
| Purchases of other assets | (1,158 | ) | (1,210 | ) | ||||
| Acquisitions of businesses, net of cash acquired | -- | (316,809 | ) | |||||
| Net cash used in investing activities of continuing operations | (476,665 | ) | (358,317 | ) | ||||
| Financing Activities | ||||||||
| Proceeds from issuance of debt | -- | 845,000 | ||||||
| Payments on debt | (140,572 | ) | (624,737 | ) | ||||
| Repurchases of common stock | (1,150,044 | ) | (16,287 | ) | ||||
| Payment of taxes withheld for vested stock awards | (22,239 | ) | (18,124 | ) | ||||
| Proceeds from the issuance of common stock | 14,183 | 15,015 | ||||||
| Net cash provided by (used in) financing activities of continuing operations | (1,298,672 | ) | 200,867 | |||||
| Discontinued Operations | ||||||||
| Operating activities | (191,642 | ) | 144,557 | |||||
| Investing activities | 2,747,684 | (2,694 | ) | |||||
| Net cash provided by discontinued operations | 2,556,042 | 141,863 | ||||||
| Increase (decrease) in cash and cash equivalents | 871,903 | (24,426 | ) | |||||
| Cash and cash equivalents at beginning of period | 202,720 | 227,146 | ||||||
| Cash and cash equivalents at end of period | $ | 1,074,623 | $ | 202,720 | ||||
Non-GAAP Financial Measurements
In addition to the GAAP results provided throughout this document, Silicon Labs has provided non-GAAP financial measurements on a basis excluding non-cash and other charges and benefits. Details of these excluded items are presented in the tables below, which reconcile the GAAP results to non-GAAP financial measurements.
The non-GAAP financial measurements do not replace the presentation of Silicon Labs’ GAAP financial results. These measurements provide supplemental information to assist management and investors in analyzing Silicon Labs’ financial position and results of operations. Silicon Labs has chosen to provide this information to investors to enable them to perform meaningful comparisons of past, present and future operating results and as a means to emphasize the results of core on-going operations.
Unaudited Reconciliation of GAAP to Non-GAAP Financial Measures
(In thousands, except per share data)
| Three Months Ended January 1, 2022 | ||||||||||||||||||||||||||||
| Non-GAAP Income Statement Items | GAAP
Measure | GAAP Percent of Revenue | Stock
Compensation Expense | Intangible
Asset Amortization | Termination Costs | Non- GAAP Measure | Non-GAAP
Percent of Revenue | |||||||||||||||||||||
| Revenues | $ | 208,680 | ||||||||||||||||||||||||||
| Gross profit | 127,831 | 61.3 | % | $ | 267 | $ | -- | $ | -- | $ | 128,098 | 61.4 | % | |||||||||||||||
| Research and development | 71,705 | 34.4 | % | 6,796 | 7,753 | -- | 57,156 | 27.4 | % | |||||||||||||||||||
| Selling, general and administrative | 53,487 | 25.6 | % | 12,863 | 2,781 | 939 | 36,904 | 17.7 | % | |||||||||||||||||||
| Operating income | 2,639 | 1.3 | % | 19,926 | 10,534 | 939 | 34,038 | 16.3 | % | |||||||||||||||||||
| Three Months Ended January 1, 2022 | ||||||||||||||||||||||||||||||||
| Non-GAAP Earnings Per Share – Continuing Operations | GAAP
Measure | Stock
Compensation Expense* | Intangible Asset Amortization* | Termination
Costs* | Investment Fair Value Adjustments* | Interest
Expense Adjustments* | Income
Tax Adjustments | Non- GAAP Measure | ||||||||||||||||||||||||
| Income from continuing operations | $ | 5,513 | $ | 19,926 | $ | 10,534 | $ | 939 | $ | (7,856 | ) | $ | 5,106 | $ | (2,670 | ) | $ | 31,492 | ||||||||||||||
| Diluted shares outstanding | 41,031 | 41,031 | ||||||||||||||||||||||||||||||
| Diluted earnings per share | $ | 0.13 | $ | 0.77 | ||||||||||||||||||||||||||||
* Represents pre-tax amounts.
Unaudited Forward-Looking Statements Regarding Business Outlook
(In millions, except per share data)
| Three Months Ending April 2, 2022 | ||||||||||||
| Business Outlook | GAAP Measure | Non-GAAP Adjustments** | Non-GAAP Measure | |||||||||
| Gross margin | 63 | % | 0 | % | 63 | % | ||||||
| Operating expenses | $ | 128 | $ | (23 | ) | $ | 105 | |||||
| Effective tax rate | 37 | % | (7 | )% | 30 | % | ||||||
| Diluted earnings per share - low | $ | 0.15 | $ | 0.43 | $ | 0.58 | ||||||
| Diluted earnings per share - high | $ | 0.25 | $ | 0.43 | $ | 0.68 | ||||||
** Non-GAAP adjustments include the following estimates: stock compensation expense of $13 million, intangible asset amortization of $10 million, and the associated tax impact from the aforementioned items.
